Notes
Pharmacology
Asthma & COPD inhalers — stepwise therapy
Mark complete
Pharmacology
Asthma & COPD inhalers — stepwise therapy
SABA, ICS, LABA, LAMA, biologics — when each gets added.
Select any text to highlight it or make a flashcard.
◆
Asthma stepwise (GINA-ish)
•
Step 1: low-dose ICS + formoterol PRN (preferred to SABA-only)
•
Step 2: daily low-dose ICS + SABA or ICS/formoterol PRN
•
Step 3: low-dose ICS-LABA (formoterol or salmeterol) + SABA
•
Step 4: medium-dose ICS-LABA
•
Step 5: high-dose ICS-LABA + LAMA (tiotropium) + consider biologic
•
Biologics: omalizumab (anti-IgE — allergic asthma), mepolizumab/benralizumab (anti-IL-5 — eosinophilic), dupilumab (anti-IL-4/13 — type 2 inflammation)
◆
COPD stepwise (GOLD)
•
Group A (low risk, few sx): SABA or SAMA PRN
•
Group B (low risk, more sx): LABA or LAMA
•
Group E (high risk regardless): LABA + LAMA; add ICS if eos ≥ 300 or frequent exacerbations
•
DON'T use ICS monotherapy in COPD (no benefit, increased pneumonia risk)
•
Roflumilast for severe COPD with chronic bronchitis + frequent exacerbations
•
Pulmonary rehab + smoking cessation + vaccines (influenza, pneumococcal, COVID) — biggest non-drug interventions
◆
Acute exacerbations
•
Asthma exacerbation: O2, nebulized albuterol + ipratropium, systemic steroids (PO if mild–moderate, IV if severe), IV magnesium if severe
•
Asthma escalation: BiPAP if respiratory failure; intubate if AMS, exhaustion, hypercapnia worsening
•
COPD exacerbation: O2 (target SpO2 88–92%), bronchodilators, steroids (prednisone 40 mg × 5 days), antibiotics (if purulent sputum, increased dyspnea, mechanical ventilation)
•
COPD severe: BiPAP if pH < 7.35 with hypercapnia and respiratory acidosis (decreases intubation rate)
◆
Side effects
•
SABA (albuterol): tachycardia, tremor, hypokalemia, hyperglycemia
•
LAMA (tiotropium): dry mouth, urinary retention (caution in BPH); paradoxical bronchospasm
•
ICS: oral candidiasis (rinse mouth), dysphonia, ↑ pneumonia in COPD, growth velocity slightly slowed in kids (catches up)
•
Theophylline (rare use): narrow therapeutic index, arrhythmia, seizures, GI
High-yield pearls
◆
Asthma + β-blocker → use cardioselective only (or avoid); non-selective can trigger bronchospasm
◆
Asthma + aspirin sensitivity + nasal polyps = Samter's triad → use leukotriene modifier (montelukast) or biologics
◆
COPD goal O2 sat 88–92% (avoid V/Q mismatch and CO2 retention)
◆
BiPAP saves intubation in COPD exacerbation with hypercapnic respiratory acidosis (pH < 7.35)
◆
ICS in COPD only when eosinophils ≥ 300 or frequent exacerbations on dual bronchodilator
Quick check
5-question quiz on this note
Test yourself before moving on. ~1 min.
Start quiz
Done reading?
Track your progress by marking this complete.
Mark complete
Next in Pharmacology